248 related articles for article (PubMed ID: 12923819)
1. Intrastriatal serotonin 5-HT2 receptors mediate dopamine D1-induced hyperlocomotion in 6-hydroxydopamine-lesioned rats.
Bishop C; Kamdar DP; Walker PD
Synapse; 2003 Nov; 50(2):164-70. PubMed ID: 12923819
[TBL] [Abstract][Full Text] [Related]
2. Serotonin 5-HT2A but not 5-HT2C receptor antagonism reduces hyperlocomotor activity induced in dopamine-depleted rats by striatal administration of the D1 agonist SKF 82958.
Bishop C; Daut GS; Walker PD
Neuropharmacology; 2005 Sep; 49(3):350-8. PubMed ID: 15993442
[TBL] [Abstract][Full Text] [Related]
3. Combined intrastriatal dopamine D1 and serotonin 5-HT2 receptor stimulation reveals a mechanism for hyperlocomotion in 6-hydroxydopamine-lesioned rats.
Bishop C; Walker PD
Neuroscience; 2003; 121(3):649-57. PubMed ID: 14568025
[TBL] [Abstract][Full Text] [Related]
4. MK-801 alters the effects of priming with L-DOPA on dopamine D1 receptor-induced changes in neuropeptide mRNA levels in the rat striatal output neurons.
Van De Witte SV; Groenewegen HJ; Voorn P
Synapse; 2002 Jan; 43(1):1-11. PubMed ID: 11746728
[TBL] [Abstract][Full Text] [Related]
5. Behavioral responsitivity to dopamine receptor agonists after extensive striatal dopamine lesions during development.
Neal-Beliveau BS; Joyce JN
Dev Psychobiol; 1998 May; 32(4):313-26. PubMed ID: 9589220
[TBL] [Abstract][Full Text] [Related]
6. Intrastriatal dopamine D1 receptor agonist-mediated motor behavior is reduced by local neurokinin 1 receptor antagonism.
Krolewski DM; Bishop C; Walker PD
Synapse; 2005 Jul; 57(1):1-7. PubMed ID: 15858838
[TBL] [Abstract][Full Text] [Related]
7. Substantia nigra glutamate antagonists produce contralateral turning and basal ganglia Fos expression: interactions with D1 and D2 dopamine receptor agonists.
McPherson RJ; Marshall JF
Synapse; 2000 Jun; 36(3):194-204. PubMed ID: 10819899
[TBL] [Abstract][Full Text] [Related]
8. Failure of MK-801 to suppress D1 receptor-mediated induction of locomotor activity and striatal preprotachykinin mRNA expression in the dopamine-depleted rat.
Campbell BM; Kreipke CW; Walker PD
Neuroscience; 2006; 137(2):505-17. PubMed ID: 16289829
[TBL] [Abstract][Full Text] [Related]
9. Chronic food restriction increases D-1 dopamine receptor agonist-induced phosphorylation of extracellular signal-regulated kinase 1/2 and cyclic AMP response element-binding protein in caudate-putamen and nucleus accumbens.
Haberny SL; Berman Y; Meller E; Carr KD
Neuroscience; 2004; 125(1):289-98. PubMed ID: 15051167
[TBL] [Abstract][Full Text] [Related]
10. NMDA receptor blockade attenuates locomotion elicited by intrastriatal dopamine D1-receptor stimulation.
Kreipke CW; Walker PD
Synapse; 2004 Jul; 53(1):28-35. PubMed ID: 15150738
[TBL] [Abstract][Full Text] [Related]
11. Interactive modulation by dopamine and serotonin neurons of receptor sensitivity of the alternate neurochemical system.
Kostrzewa RM; Brus R; Perry KW
Pol J Pharmacol; 1999; 51(1):39-47. PubMed ID: 10389143
[TBL] [Abstract][Full Text] [Related]
12. Serotonin 5-HT2A receptors underlie increased motor behaviors induced in dopamine-depleted rats by intrastriatal 5-HT2A/2C agonism.
Bishop C; Tessmer JL; Ullrich T; Rice KC; Walker PD
J Pharmacol Exp Ther; 2004 Aug; 310(2):687-94. PubMed ID: 15044557
[TBL] [Abstract][Full Text] [Related]
13. Serotonin (5-HT) systems mediate dopamine (DA) receptor supersensitivity.
Kostrzewa RM; Gong L; Brus R
Acta Neurobiol Exp (Wars); 1993; 53(1):31-41. PubMed ID: 8317265
[TBL] [Abstract][Full Text] [Related]
14. Dopamine D1 and D2 receptor-mediated acute and long-lasting behavioral effects of glial cell line-derived neurotrophic factor administered into the striatum.
Kobayashi S; Ogren SO; Hoffer BJ; Olson L
Exp Neurol; 1998 Dec; 154(2):302-14. PubMed ID: 9878169
[TBL] [Abstract][Full Text] [Related]
15. Interhemispheric modulation of dopamine receptor interactions in unilateral 6-OHDA rodent model.
Lawler CP; Gilmore JH; Watts VJ; Walker QD; Southerland SB; Cook LL; Mathis CA; Mailman RB
Synapse; 1995 Dec; 21(4):299-311. PubMed ID: 8869160
[TBL] [Abstract][Full Text] [Related]
16. Role of the 5-HT2 receptor in the methamphetamine-induced neurochemical alterations.
Johnson M; Sonsalla PK; Letter AA; Hanson GR; Gibb JW
J Pharmacol Exp Ther; 1994 Jul; 270(1):97-103. PubMed ID: 7913500
[TBL] [Abstract][Full Text] [Related]
17. Serotonin 1B receptor stimulation reduces D1 receptor agonist-induced dyskinesia.
Jaunarajs KL; Dupre KB; Steiniger A; Klioueva A; Moore A; Kelly C; Bishop C
Neuroreport; 2009 Sep; 20(14):1265-9. PubMed ID: 19633584
[TBL] [Abstract][Full Text] [Related]
18. The atypical dopamine D1 receptor agonist SKF 83959 induces striatal Fos expression in rats.
Wirtshafter D; Osborn CV
Eur J Pharmacol; 2005 Dec; 528(1-3):88-94. PubMed ID: 16324697
[TBL] [Abstract][Full Text] [Related]
19. Alleviation of motor hyperactivity and neurochemical deficits by endocannabinoid uptake inhibition in a rat model of Huntington's disease.
Lastres-Becker I; Hansen HH; Berrendero F; De Miguel R; Pérez-Rosado A; Manzanares J; Ramos JA; Fernández-Ruiz J
Synapse; 2002 Apr; 44(1):23-35. PubMed ID: 11842443
[TBL] [Abstract][Full Text] [Related]
20. Neonatal dopamine depletion reveals a synergistic mechanism of mRNA regulation that is mediated by dopamine(D1) and serotonin(2) receptors and is targeted to tachykinin neurons of the dorsomedial striatum.
Campbell BM; Gresch PJ; Walker PD
Neuroscience; 2001; 105(3):671-80. PubMed ID: 11516832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
